Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.

[1]  R. Dockhorn,et al.  273 Low doses of inhaled fluticasone propionate (FP) reduce bronchial hyperresponsiveness (BHR) , 1996 .

[2]  C. Jackson,et al.  Optimizing inhaled drug delivery in patients with asthma. , 1995, The British journal of general practice : the journal of the Royal College of General Practitioners.

[3]  S. Pedersen,et al.  Budesonide treatment of moderate and severe asthma in children: a dose-response study. , 1995, The Journal of allergy and clinical immunology.

[4]  R. Dockhorn,et al.  Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. , 1994, The Journal of allergy and clinical immunology.

[5]  P. Barnes,et al.  Efficacy and Safety of Inhaled Corticosteroids in Asthma , 1993 .

[6]  T. Haahtela,et al.  Airway mucosal inflammation even in patients with newly diagnosed asthma. , 1993, The American review of respiratory disease.

[7]  D. Postma,et al.  A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. , 1992, The New England journal of medicine.

[8]  R. N. Brogden,et al.  Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. , 1992, Drugs.

[9]  D. Geddes,et al.  Inhaled corticosteroids: benefits and risks. , 1992, Thorax.

[10]  T. Haahtela,et al.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. , 1991, The New England journal of medicine.

[11]  A. Tattersfield,et al.  Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. , 1991, The American review of respiratory disease.

[12]  E. Juniper,et al.  Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. , 1990, The American review of respiratory disease.

[13]  P. Barnes,et al.  A new approach to the treatment of asthma. , 1989, The New England journal of medicine.

[14]  J. Baskerville,et al.  Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. , 1989, The Journal of allergy and clinical immunology.

[15]  B. Karlson,et al.  Comparison of dose‐response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma , 1989, Allergy.

[16]  H. Folgering,et al.  Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma. , 1989, The European respiratory journal.

[17]  H. Sluiter,et al.  Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. , 1988, The American review of respiratory disease.

[18]  J. Morris,et al.  Fifteen-year interval spirometric evaluation of the Oregon predictive equations. , 1988, Chest.

[19]  A. Lahdensuo,et al.  Effect of inhaled budesonide on severe steroid-dependent asthma. , 1987, European journal of respiratory diseases.

[20]  B. Weeke,et al.  High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. , 1986, European journal of respiratory diseases.

[21]  S. Johansson,et al.  Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide. , 1983, British journal of clinical pharmacology.

[22]  J. Baskerville,et al.  Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. , 1982, The Journal of allergy and clinical immunology.

[23]  R. Pauwels,et al.  Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. , 1982, European journal of respiratory diseases. Supplement.

[24]  N. Lefcoe,et al.  A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. , 1977, Journal of Allergy and Clinical Immunology.

[25]  Whitehead Rg.  Letter: Protein requirement. , 1974, Lancet.

[26]  K. Palmer,et al.  Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. , 1973, Lancet.